Newsfeeds - Spark Newswire - Page 7

Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Read More

2 minute read

FDA
News

Vir Biotechnology Announces New Research Describing Structural Basis Of SARS-CoV-2 Omicron Immune Evasion And Receptor Engagement

By Benzinga Newsdesk

Today, 11:26 PM

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced new preclinical research published to the preprint server bioRxiv, describing the structural basis and magnitude by which the new SARS-CoV-2 Omicron variant

Read More

2 minute read

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year

By Shanthi Rexaline

Today, 11:26 PM

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating sentiment.

Read More

1 minute read

‘In @WHCOVIDResponse briefing, Zients gives update on supply in what he calls the nation’s medicine cabinet for #covid19. In Jan.: 265K courses of Pfizer drug, 3M of Merck drug (if authorized), 500K+ of AZN preventive antibody, 300K of Vir/GSK antibody…

By Benzinga Newsdesk

Today, 11:26 PM

https://twitter.com/megtirrell/status/1473750991296208909

Read More

5 minute read

55 Biggest Movers From Yesterday

Today, 11:26 PM

Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday.

Read More

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 11:26 PM

Read More

8 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For December 21, 2021

By Benzinga Insights

Today, 11:26 PM

Read More

1 minute read

Baird Downgrades Vir Biotechnology to Underperform, Announces $36 Price Target

By Benzinga Newsdesk

Today, 11:26 PM

Baird analyst Joel Beatty downgrades Vir Biotechnology (NASDAQ:VIR) from Neutral to Underperform and announces $36 price target.

Read More

1 minute read

Glaxo-Vir Biotech’s Antibody Approved In Europe For Early Treatment Of COVID-19

By Vandana Singh

Today, 11:26 PM

The

Read More

4 minute read

46 Biggest Movers From Yesterday

Today, 11:26 PM

Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday.

Read More

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 11:26 PM